Related by context. Frequent words. (Click for all words.) 64 Phase 2a trial 62 Phase 2b study 62 pivotal Phase III 62 Phase III clinical 62 Phase 2a clinical 62 Special Protocol Assessment 62 unblinded 61 pralatrexate 61 Investigational Device Exemption IDE 61 confirmatory Phase 3 61 Phase 2b trial 61 efficacy endpoints 61 Phase 2b clinical 60 Phase III pivotal 60 pivotal Phase 60 Phase Ib 60 clinical trial 60 Phase IIb 60 phase IIb 59 Board DSMB 59 talactoferrin 59 Phase IIa trial 59 sodium Injection 59 Phase IIb clinical 58 Zerenex 58 randomized Phase 58 Phase IIa clinical 58 Phase 2a 58 FavId 58 Phase III 58 FOLOTYN 58 DSMB 58 Phase 1b 57 L MTP PE 57 Phase 1b clinical 57 multiple ascending dose 57 CoFactor 57 HGS ETR1 57 dose escalation 57 Phase IIb trial 57 tolerated dose MTD 57 elagolix 57 clinical trials 56 Phase IIa 56 clinical endpoints 56 Phase III clinical trials 55 MGCD# [001] 55 vernakalant oral 55 denufosol 55 PROMACTA 55 PS# [001] 55 phase 2a 55 methylnaltrexone 55 dose escalation trial 55 dose escalation study 54 ALN VSP 54 HspE7 54 SPIRIT III 54 Phase 2b 54 Mylotarg 54 ridaforolimus 54 pegloticase 54 LymphoStat B 54 substudy 54 AP# [003] 54 Marketing Authorization Application 54 velaglucerase alfa 53 TORISEL 53 dimebon 53 Azixa 53 pharmacokinetic 53 ZYBRESTAT 53 placebo controlled 53 preclinical studies 53 refractory multiple myeloma 53 ALN RSV# 53 BAY #-# 53 vilazodone 53 LibiGel 53 Pharmion Corporation 53 Topical Interferon Alpha 2b 53 satraplatin 53 Taxotere ® 53 brentuximab vedotin 53 placebo controlled trials 53 Biologics License Application 53 Phase III trials 53 PXD# 53 multicenter 53 INCB# [002] 53 APF# 53 ONCONASE 52 telbivudine 52 ONGLYZA 52 randomized clinical 52 Zenvia 52 randomized controlled clinical 52 JANUVIA 52 label dose escalation 52 multicenter randomized double 52 ISENTRESS